Legal·October 22, 2026·2 min read

Supreme Court keeps transgender inmate care restrictions blocked

Trump administration cannot enforce policy while legal challenge continues

Illustration representing court rulings and legal proceedings.
IllustrationIllustration representing court rulings and legal proceedings.AI-generated illustration

The U.S. Supreme Court refused on October 21 to let the Trump administration immediately enforce new restrictions on medical treatment for transgender people in federal prisons, leaving a lower-court injunction in place while the underlying lawsuit continues.

The brief order did not explain the court's reasoning and did not decide whether the administration's policy is ultimately constitutional. Justices Samuel Alito and Clarence Thomas said they would have allowed the restrictions to take effect while litigation proceeds. The practical result is that federal prisons must continue providing treatments covered by the lower court's order for now.

The policy followed an executive order from President Trump directing the Federal Bureau of Prisons to revise its treatment policies so federal money would not be spent for the purpose of changing an inmate's appearance to that of the opposite sex. Under the resulting policy, prisons would halt gender-transition surgeries, gradually discontinue hormone therapy and end accommodations including makeup and wigs. Mental health services would continue.

Transgender inmates challenged the restrictions, and U.S. District Judge Royce Lamberth ordered the Bureau of Prisons to continue treatment. Lamberth cited evidence that untreated gender dysphoria can lead to serious effects including depression, anxiety and suicidal thoughts. A divided federal appeals court subsequently left his injunction in place, prompting the administration to seek emergency relief from the Supreme Court.

Court records cited by the Associated Press show about 600 federal inmates were receiving hormone therapy in 2025. Attorneys for the inmates said the government had not provided evidence connecting hormone therapy to security problems during approximately three decades in which it had been available within the federal prison system. The administration argued that the treatments raised security concerns and could no longer be justified.

The case now returns to the lower courts, where the legal challenge to the policy will continue. The Supreme Court could potentially confront the broader constitutional questions later if the case returns after further litigation.

Community discussion
"Should federal prison medical policies be determined primarily by medical standards or by broader correctional and security considerations?"